Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Legislation & Advocacy

U.S. House Vote Looms; Trump Struggles to Win Obamacare Repeal


David Morgan and Richard Cowan  |  March 23, 2017

WASHINGTON (Reuters)—U.S. President Donald Trump made a final push on Thursday to win over skeptical members of his own Republican Party to begin dismantling Obamacare in the House of Representatives or risk failure on one of his top legislative priorities. The effort is seen by financial markets as a crucial test of Trump’s ability to…

Uncertain Fate of Obamacare Causes Some Hospitals to Halt Projects, Hiring

Robin Respaut and Yasmeen Abutaleb  |  March 23, 2017

WASHINGTON (Reuters)—Uncertainty surrounding the Republican plan to replace Obamacare is forcing some U.S. hospitals to delay expansion plans, cut costs, or take on added risk to borrow money for capital investment projects, dealing an economic blow to these facilities and the towns they call home. Hospitals typically lay out multi-year operating plans that prioritize investments,…

Trump Appears to Be Losing Battle Ahead of Healthcare Vote

David Morgan and Susan Cornwell  |  March 23, 2017

WASHINGTON (Reuters)—U.S. President Donald Trump and Republican congressional leaders appeared on Wednesday to be losing the battle to get enough support in the House of Representatives to pass their Obamacare rollback bill, watched by wary investors in financial markets. The current House Republican rollback plan is scheduled for a floor vote on Thursday but faces…

Republicans Revamp U.S. Health Bill, Boost Benefits to Older Americans

Susan Cornwell & Valerie Volcovici  |  March 21, 2017

WASHINGTON (Reuters)—U.S. House Republicans are working on changes to their healthcare overhaul bill to provide more generous tax credits for older Americans and add a work requirement for the Medicaid program for the poor, House Speaker Paul Ryan (R-Wis.) said on Sunday. Ryan said Republican leaders still planned to bring the healthcare bill to a…

Scant Consumer Information in Local TV Coverage of Obamacare

Lisa Rapaport  |  March 19, 2017

(Reuters Health)—Local TV news coverage of the Affordable Care Act (ACA), often called Obamacare, generally focused more on politics than on information consumers can use to help choose insurance, a recent study suggests. Overall, less than half of ACA-related news coverage focused on health insurance products, while much of the rest of the spots concentrated…

Not Much Saving Going on in Health Savings Accounts

Beth Pinsker  |  March 19, 2017

NEW YORK (Reuters)—Health savings accounts (HSAs) feature prominently in the new healthcare bill being considered by the U.S. House of Representatives, with a variety of changes in store. But research shows not many participants are actually saving money beyond the initial tax break. More than 20 million Americans currently have these accounts, which allow people…

AHCA, ACR Health Policy & More

Angus B. Worthing  |  March 16, 2017

Editor’s note: This blog by Dr. Worthing originally appeared on the ACR’s Advocacy Listserv. What a month! House Republicans introduced their bill to repeal and replace Obamacare. The ACR has analyzed the bill and believes the American Health Care Act (AHCA) does not go far enough to help Americans with rheumatic diseases. Brief recap: The…

ACR Joins Opposition to Proposed Healthcare Replacement Bill as Written

Mary Beth Nierengarten  |  March 16, 2017

The ACR is joining a chorus of voices asking Congress to reconsider several key provisions in the proposed American Health Care Act (AHCA) that it feels could have a detrimental effect on patients. Characterized as a replacement to the Affordable Care Act (ACA), the AHCA eliminates a number of provisions found in the ACA, although…

Agency’s Analysis of U.S. Republican Health Bill May Sharpen Resistance to Measure

David Lawder  |  March 13, 2017

WASHINGTON (Reuters)—A non-partisan report released Monday on the costs of a Republican plan to replace the Obamacare healthcare law could harden opposition to the proposal, adding to the obstacles facing President Donald Trump’s first major legislative effort. The Congressional Budget Office, which provides official cost estimates for legislation, is widely expected to find the Republican…

Trump Chooses Gottlieb to Run FDA; Pharma Breathes Sigh of Relief

Toni Clarke  |  March 13, 2017

WASHINGTON (Reuters)—U.S. President Donald Trump has chosen Dr. Scott Gottlieb, a conservative health policy expert with deep ties to the pharmaceutical industry, to lead the U.S. Food and Drug Administration, the White House said on Friday. If confirmed by the Senate, Gottlieb would be in charge of implementing Trump’s plan to dramatically cut regulations governing…

  • « Previous Page
  • 1
  • …
  • 47
  • 48
  • 49
  • 50
  • 51
  • …
  • 86
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences